Bright Eye Hospital released its 2026 interim report on August 29, 2026. During the reporting period, the company achieved total operating revenue of 1.602 billion yuan, net profit attributable to the parent company of 88.1088 million yuan, and net cash inflow from operating activities of 333 million yuan. The company's latest asset-liability ratio was 54.57 percent, an increase of 1.12 percentage points compared with the same period last year. Gross margin was 39.09 percent, a decrease of 2.01 percentage points from the previous quarter. Return on equity was 4.14 percent. Diluted earnings per share were 0.59 yuan. Total asset turnover was 0.34 times, and inventory turnover was 4.55 times, down 13.79 percent year on year. The company had 10,500 shareholders, and the top ten shareholders held 88.5141 million shares, accounting for 59.16 percent of total share capital.
Chengdu Bright Eye Hospital Co. Ltd.Interim report shows net profit of 88.1M yuan, but gross margin declined and asset-liability ratio rose, mixed results.